Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

10 essential questions to ask when diagnosed with bladder cancer

Naeem Rahman, MD
Conditions
January 9, 2019
160 Shares
Share
Tweet
Share

Over 80,000 new cases of bladder cancer are diagnosed every year. Of the new cases, over 62,000 are men, and over 18,000 are women. Whites have higher incidence rates than blacks, although black patients have higher mortality rates, particularly black women. The majority of cases are found with painless gross hematuria (although most patients with gross painless hematuria don’t have bladder cancer). Nearly 80 percent of patients diagnosed with bladder cancer will survive beyond five years. When confronting bladder cancer, these are the ten questions that are essential to ask your urologist:

1. What (cell) type of bladder cancer is present?

There are various cell/tumor types with different biological behavior and risk factors. The majority of bladder cancers that we deal with are urothelial cancers (previously known as transitional cell cancer, named after the cell type prevalent along the lining of the bladder). Smoking is the greatest risk factor for this tumor, and a small but significant percentage of these patients can have tumor sites within the kidneys and ureters (tubes that bring urine down from the bladder). Other variants seen less commonly in the U.S. include squamous cell cancer, although patients who have chronic catheters or self catheterize are at increased risk to develop this variant.

2. How large is the tumor?

Like any other cancer, the size of the tumor has implications for treatment success. Tumors above 3 to 4 cm will likely need multiple procedures, are more likely to recur and will need additional therapy.

3. Are there multiple tumors?

Similar to the size, the number of tumors is an indicator of the need for multiple procedures and recurrence risk.

4. How does the tumor look?

The morphological features of bladder cancer are distinct. Its gross appearance gives us clues about its aggressiveness. Tumors that are on a broad base and sessile (immobile) are higher risk and worrisome, while tumors that appear papillary (or finger-like) or pedunculated (having a stalk) are lower risk and more curable.

5. Is the tumor high grade or low grade?

Cancer grade is reflective of how close the cancer cells are to their original cell. The closer the cells look to a normal cell and the more organized their growth pattern, the lower the grade of cancer and hence less likely to spread or return. The converse is true as well – the more different or bizarre cells appear and the more disorderly the growth pattern, the higher the grade, and the more likely the tumor is to recur and spread to other sites.

6. How deep is the tumor?

The bladder is made up of 4 concentric layers (in order from superficial to deep): mucosa, lamina propria (connective tissue layer), muscle, and fat. Tumors that have invaded into the muscle layer are considered high risk, more likely to spread, and become metastatic. These tumors generally require systemic chemotherapy followed by radical surgery to remove the bladder. Tumors within mucosa and lamina propria are considered superficial.

7. Is there carcinoma in situ?

Carcinoma in situ is a flat, superficial lesion which is high grade. It is counterintuitive in a sense because although superficial, it is considered aggressive cancer and requires adjuvant treatment (see below).

8. What are the chances the tumor recurs?

Tumors that are high grade, more penetrating (at least into the lamina propria or second layer), larger than 2 cm and multiple in nature are likely to recur. The natural history of bladder cancer is for recurrence, so low-grade cancers can recur as well. As a result, frequent cystoscopies (fiber-optic scope placed into the bladder, done in the office) are in order, usually for a lifetime (I have seen tumors come back after 15 years of indolence); every 3 to 6 months in the first three years.

Smoking cessation for those who are still actively smoking has been shown to decrease recurrence rates.

9. What are the risks of treatment?

Initial treatment is surgical via a transurethral resection (endoscopic treatment via the urethra to cut and shave the tumor out in piecemeal fashion). Risks include tearing the bladder wall, need for a catheter to help heal and decompress the bladder, bloody urine output requiring observation and irrigation, and several weeks of urinary burning.

10. Do I need adjuvant therapy?

The need for adjuvant therapy is predicated by the aggressiveness of the cancer. Tumors that are classified as superficial (haven’t invaded into the muscle layer of the bladder) but are high grade or have had a quick recurrence need adjuvant bladder instillation therapy. The standard of care is to administer Bacillus Calmette-Guerin (or BCG) into the bladder at weekly intervals after the bladder has healed from surgery (usually 2 to 4 weeks). BCG is an attenuated form of tuberculosis (once used as a vaccine in Europe and Asia, less so in the U.S.), administered into the bladder at weekly intervals usually for six weeks (induction course). Maintenance protocols after initial therapy are often indicated as well. For muscle-invasive cancers, referral to a medical oncologist for chemotherapy is indicated, usually followed by radical surgery.

Naeem Rahman is a urologist and can be reached at his self-titled site, Naeem Rahman, M.D.

Image credit: Shutterstock.com

Prev

A story of missed opportunities and medical missteps

January 9, 2019 Kevin 3
…
Next

Qualifying conditions for medical marijuana

January 9, 2019 Kevin 0
…

Tagged as: Oncology/Hematology, Urology

Post navigation

< Previous Post
A story of missed opportunities and medical missteps
Next Post >
Qualifying conditions for medical marijuana

More by Naeem Rahman, MD

  • 10 questions men must ask about their urinary symptoms

    Naeem Rahman, MD
  • Excellent surgeons are those who are quick to recognize their mistakes

    Naeem Rahman, MD
  • Diagnosed with prostate cancer? You must ask these 10 questions.

    Naeem Rahman, MD

Related Posts

  • Questions about pharma pricing and marketing

    Martha Rosenberg
  • My first patient to be diagnosed with cancer

    Ton La, Jr., MD, JD
  • Hormone replacement therapy is still linked to cancer

    Martha Rosenberg
  • We have a shot at preventing cervical cancer

    Lisa N. Abaid, MD, MPH
  • Obstruction of medical justice: How health care fails patients with cancer

    Miriam A. Knoll, MD
  • Despite progress in cancer care, cost and equity challenges still must be addressed

    David M. Aboulafia, MD

More in Conditions

  • Overcoming the lies of depression: Senator John Fetterman’s struggle with mental health

    Harvey Max Chochinov, MD, PhD
  • Proposed USPSTF guideline update: Advocating for earlier breast cancer screening at age 40

    Hoag Memorial Hospital Presbyterian
  • The rising threat of lung cancer in Asian American female nonsmokers

    Alice S. Y. Lee, MD
  • Urgent innovation needed to address growing mental health crisis among children and families

    Monika Roots, MD
  • The importance of listening in health care: a mother’s journey advocating for children with chronic Lyme disease

    Cheryl Lazarus
  • The unjust reality of racial disparities in pediatric kidney transplants

    Lien Morcate
  • Most Popular

  • Past Week

    • Is chaos in health care leading us towards socialized medicine? How physician burnout is a catalyst.

      Howard Smith, MD | Physician
    • Boxing legends Tyson and Foreman: powerful lessons for a resilient and evolving health care future

      Harvey Castro, MD, MBA | Physician
    • A physician’s typical day, as envisioned by a non-clinician health care MBA: a satire

      Jennifer Lycette, MD | Physician
    • Revealing America’s expansion: the dark truth of Native American suffering and unjustified abuses

      Anonymous | Physician
    • The tragic story of Mr. G: a painful journey towards understanding suicide

      William Lynes, MD | Physician
    • Decoding name displays in health care: Privacy, identification, and compliance unveiled

      Deepak Gupta, MD | Physician
  • Past 6 Months

    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Unveiling the hidden damage: the secretive world of medical boards

      Alan Lindemann, MD | Physician
    • An inspiring tribute to an exceptional radiologist who made a lasting impact

      Kim Downey, PT | Conditions
    • Proactive risk management: a game-changer in preventing physician burnout

      Howard Smith, MD | Physician
  • Recent Posts

    • Unmasking the truth: the shocking reality of the opioid epidemic and who’s really to blame

      Jay K. Joshi, MD | Physician
    • Discover your true north: Navigating life’s confusions and embracing your path to success

      Tyler Jorgensen, MD | Physician
    • A revolution in patient empowerment: Working together to save our medical system [PODCAST]

      The Podcast by KevinMD | Podcast
    • Revealing America’s expansion: the dark truth of Native American suffering and unjustified abuses

      Anonymous | Physician
    • Unlock financial freedom: The physician’s guide to lucrative multifamily syndications and wealth accumulation

      Pranay Parikh, MD | Finance
    • From Moscow Mule to the opioid crisis: Unveiling the tragic legacy and urgent solutions

      Osmund Agbo, MD | Meds

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Checkpoint Blockade Stumbles in Advanced EGFR-Mutant NSCLC
  • Secret Past of Slain Doctor; Pope Needs Intestinal Surgery; More MIs on Mondays
  • New Antiviral Option for CMV Prophylaxis After Kidney Transplant
  • Antibody for Infant RSV Prevention to Face FDA Panel
  • Is Getting Test Results Online Right Away a Good Idea? Yes, Patients Say

Meeting Coverage

  • Checkpoint Blockade Stumbles in Advanced EGFR-Mutant NSCLC
  • Phase II Study: Bispecific Oral Drug Tops Leading JAK Inhibitor for RA
  • Closing the Diversity Gaps in Urologic Oncology Leadership
  • Certain NSCLC Patients May Be Able to Stop Immunotherapy at 2 Years
  • No Survival Benefit With Immune Checkpoint Inhibitor Rechallenge in Metastatic RCC
  • Most Popular

  • Past Week

    • Is chaos in health care leading us towards socialized medicine? How physician burnout is a catalyst.

      Howard Smith, MD | Physician
    • Boxing legends Tyson and Foreman: powerful lessons for a resilient and evolving health care future

      Harvey Castro, MD, MBA | Physician
    • A physician’s typical day, as envisioned by a non-clinician health care MBA: a satire

      Jennifer Lycette, MD | Physician
    • Revealing America’s expansion: the dark truth of Native American suffering and unjustified abuses

      Anonymous | Physician
    • The tragic story of Mr. G: a painful journey towards understanding suicide

      William Lynes, MD | Physician
    • Decoding name displays in health care: Privacy, identification, and compliance unveiled

      Deepak Gupta, MD | Physician
  • Past 6 Months

    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Unveiling the hidden damage: the secretive world of medical boards

      Alan Lindemann, MD | Physician
    • An inspiring tribute to an exceptional radiologist who made a lasting impact

      Kim Downey, PT | Conditions
    • Proactive risk management: a game-changer in preventing physician burnout

      Howard Smith, MD | Physician
  • Recent Posts

    • Unmasking the truth: the shocking reality of the opioid epidemic and who’s really to blame

      Jay K. Joshi, MD | Physician
    • Discover your true north: Navigating life’s confusions and embracing your path to success

      Tyler Jorgensen, MD | Physician
    • A revolution in patient empowerment: Working together to save our medical system [PODCAST]

      The Podcast by KevinMD | Podcast
    • Revealing America’s expansion: the dark truth of Native American suffering and unjustified abuses

      Anonymous | Physician
    • Unlock financial freedom: The physician’s guide to lucrative multifamily syndications and wealth accumulation

      Pranay Parikh, MD | Finance
    • From Moscow Mule to the opioid crisis: Unveiling the tragic legacy and urgent solutions

      Osmund Agbo, MD | Meds

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...